OLMAT MT 25

About

Olmat MT 25 combines Olmesartan Medoxomil and Metoprolol Succinate, offering a dual-action approach to managing hypertension. Olmesartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II, thereby lowering blood pressure. Metoprolol is a beta-blocker that works by slowing down the heart rate and relaxing blood vessels, further contributing to blood pressure reduction and reducing the heart's workload. This combination therapy is particularly effective for patients whose blood pressure is not adequately controlled by monotherapy. It provides comprehensive cardiovascular protection by addressing multiple pathways involved in blood pressure regulation, leading to improved outcomes and reduced risk of cardiovascular events.

Uses

• Treatment of essential hypertension not controlled by monotherapy.
• Reduction of cardiovascular risk in hypertensive patients.
• Management of high blood pressure with associated tachycardia.
• Improvement of blood pressure control and patient adherence.

Directions For Use

Take this medicine once daily, preferably at the same time each day, with or without food, as directed by your doctor. Do not crush or chew the tablet.

Benefits

• Provides effective and sustained blood pressure control.
• Reduces heart rate and workload on the heart.
• Offers comprehensive cardiovascular protection.
• Improves blood pressure control in resistant hypertension.
• Combines two different mechanisms of action for synergy.
• Reduces the risk of heart attack and stroke.

Side Effects

• Dizziness
• Fatigue
• Headache
• Nausea
• Diarrhea
• Bradycardia (slow heart rate)
• Cold extremities
• Shortness of breath (especially in susceptible individuals)
• Hypotension (low blood pressure)
• Insomnia
• Depression
• Erectile dysfunction

Safety Measures

• Alcohol - May enhance the blood pressure-lowering effect and increase dizziness. Limit alcohol intake.
• Pregnancy - Contraindicated during the second and third trimesters due to risk of fetal harm. Consult a doctor immediately if pregnant.
• Breastfeeding - Not recommended during breastfeeding due to potential adverse effects on the infant.
• Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be necessary.
• Kidney - Use with caution in patients with renal artery stenosis or severe renal impairment; monitor kidney function closely.
• Lung - Use with caution in patients with asthma or severe COPD, as beta-blockers can worsen bronchospasm.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.